Hawthorne Cat Promotes New Financing Offers

San Diego, CA (PRWEB) February 08, 2016

Hawthorne Cat, the exclusive Cat® equipment dealer in San Diego, the Hawaiian Islands and the Pacific Region announces new ways to save when you use your Cat Financial Commercial Account. Take advantage of limited time special financing deals on work tools, machine and engine parts, and new or reman Cat marine parts. Offers are valid through December 31, 2016.

Greg Pino, Regional Product Support Sales Manager, says, "No matter where your jobs take you, Commercial Account is a quick and easy way to pay for your expenses." Pino continues, "Use your account to pay for anything offered at any Hawthorne location in San Diego, Hawaii, and Guam."

0% on Machine and Engine Parts | Receive 0% financing up to 18 months, 1.9% for 24 months, or 2.9% up to 36 months on new or reman Cat parts, with or without service, for machines and engines when you use your Cat Financial Commercial Account.

0% on Cat Work Tools | Use your Cat Financial Commercial Account for 0% financing up to 24 months on Cat Work Tools.

15% Future Parts Credit for New Marine Customers | Receive 15% future parts credit on new or reman Cat marine parts with purchase of a qualifying rebuild on a Cat Marine engine.

Visit the Hawthorne Cat website to learn more about the special deals available with your Cat Financial Commercial Account. Contact your Hawthorne Product Support Sales Representative for complete details.

About Hawthorne Cat
Hawthorne Cat is the authorized dealer for Cat construction and power equipment in San Diego, Hawaii, Guam, Saipan and American Samoa. Hawthorne sells, rents, provides parts and service, training and emission solutions to various industries including general building construction, landscaping, marine, paving and power generation. For more on Hawthorne Cat, visit http://www.hawthornecat.com.

Read the full story at http://www.prweb.com/releases/2016/02/prweb13203226.htm

You May Also Be Interested In

• Moleculin Biotech (NASDAQ:MBRX) Participates in Virtual Investor "What This Means" Segment Hosted by JTC Team
• Exegenesis Bio to Present 9-Patient Data from a Phase 1/2 Clinical Trial of EXG001-037, a Novel rAAV Gene Therapy for Spinal Muscular Atrophy (SMA) Type 1: Improved Head Control and Sitting Without Ex
• Hyundai Bioscience's antiviral for Dengue Fever to enter clinical trials in Brazil